SSRI antidepressant

  • Major Depression
  • Social Anxiety
  • Anti-cholinergic risks
  • Panic
  • PTSD
  • WD risks

Dosing

(mg/d): Depression (20), Anxiety disorders (40-60), OCD (60-80).

Management

Side effects: apathy, sexual dysfunction, sleep disruption, nausea, restless legs, akathisia. Warning: osteopenia in post-menopausal women. Raises levels of meds metabolized through CYP 2D6, 3A4, 2B6. Raise dose by x1.3 if using with carbamazepine.

Worst SSRI overall (WD risk, cognitive impairment, pregnancy teratogen, weight gain, sedation, anticholinergic and antihistaminergic).

EMR Text

Diagnosis1

StartText1

WarningText1

Diagnosis2

StartText2

WarningText2

Scroll to Top